SWP
HURA

Stratos Wealth Partners’s TuHURA Biosciences HURA Stock Holding History

Stratos Wealth Partners’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-571
Closed -$3.39K – 1463
2023
Q4 		$3.39K Buy
+571
New +$29.5K ﹤0.01% 1372

Other funds holding HURA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Stratos Wealth Partners's HURA Position: Q1 2024 in Review

Stratos Wealth Partners sold out of TuHURA Biosciences (HURA) in Q1 2024, closing a stake of 571 shares — an estimated $3.39K sold.

Stratos Wealth Partners first reported a position in HURA in Q4 2023 and held it in 1 quarter. The position peaked at $3.39K in Q4 2023. 13 funds tracked by Wall St. Rank hold HURA as of Q1 2024.

  • Stratos Wealth Partners reported no remaining TuHURA Biosciences position as of Q1 2024 after selling out during the quarter.
  • Stratos Wealth Partners sold 571 TuHURA Biosciences shares in Q1 2024, an estimated $3.39K.
  • Stratos Wealth Partners first reported a position in TuHURA Biosciences in Q4 2023 and held it in 1 quarter.
  • Stratos Wealth Partners's TuHURA Biosciences position peaked at $3.39K in Q4 2023.
  • 13 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2024.

Based on Stratos Wealth Partners's 13F filing for Q1 2024, filed 16 Apr 2024.